Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

Roy S. Herbst, Jean‐Charles Soria, Marcin Kowanetz et al. · Nature · 2014 · 5.2K citations

Medicine, Biomarker Target, Anti-pd-l1 Antibody Mpdl3280a +10

Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence

Rebecca Dent, Maureen Trudeau, Kathleen I. Pritchard et al. · Clinical Cancer Research · 2007 · 5K citations · Full text

Regulatory T Cells Exhibit Distinct Features in Human Breast Cancer

George Plitas, Catherine Konopacki, Kenmin Wu et al. · Immunity · 2016 · 682 citations · Full text

Breast Oncology, Cancer Immunosurveillance, T-regulatory Cell +9

Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth

Giovanni Germano, Simona Lamba, Giuseppe Rospo et al. · Nature · 2017 · 608 citations

Chromatin, Genome Instability, Dna Damage +12

The Novel Role of Tyrosine Kinase Inhibitor in the Reversal of Immune Suppression and Modulation of Tumor Microenvironment for Immune-Based Cancer Therapies

Junko Ozao‐Choy, Ge Ma, Johnny Kao et al. · Cancer Research · 2009 · 528 citations · Full text

T-regulatory Cell, Immunology, Immunoediting +17